Scandipharm Inc
✅ Low Risk
FEI: 3004761303 • Hoover, AL • UNITED STATES
FEI Number
3004761303
Location
Hoover, AL
Country
UNITED STATESAddress
22 Inverness Center Pkwy, , Hoover, AL, United States
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
SACCHARIN
The article contains Saccharin, a non-nutritive sweetner, and its label or labeling fails to bear the required warning statement.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 1/5/2011 | 41GHT03ORAL REHYDRATION PRODUCTS | 487SACCHARIN | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Scandipharm Inc's FDA import refusal history?
Scandipharm Inc (FEI: 3004761303) has 1 FDA import refusal record(s) in our database, spanning from 1/5/2011 to 1/5/2011.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Scandipharm Inc's FEI number is 3004761303.
What types of violations has Scandipharm Inc received?
Scandipharm Inc has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Scandipharm Inc come from?
All FDA import refusal data for Scandipharm Inc is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.